Canada Pension Plan Investment Board Rapt Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $1.26 Million - $2.8 Million	-70,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $1.12 Million - $1.71 Million	70,000 New	70,000 $1.55 Million
Q4 2020 Feb 17, 2021	SELL	$15.89 - $40.87 $1.59 Million - $4.09 Million	-100,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$21.6 - $37.5 $2.16 Million - $3.75 Million	100,000 New	100,000 $3.22 Million

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.